vs

Side-by-side financial comparison of Immunocore Holdings plc (IMCR) and FIRST FINANCIAL CORP (THFF). Click either name above to swap in a different company.

Immunocore Holdings plc is the larger business by last-quarter revenue ($104.5M vs $70.5M, roughly 1.5× FIRST FINANCIAL CORP). On growth, Immunocore Holdings plc posted the faster year-over-year revenue change (24.3% vs 14.1%). FIRST FINANCIAL CORP produced more free cash flow last quarter ($86.4M vs $-35.5M). Over the past eight quarters, Immunocore Holdings plc's revenue compounded faster (21.7% CAGR vs 20.8%).

Immunocore is a global commercial-stage biotechnology company, based in Oxfordshire, which researches and develops biological drugs using soluble T-cell receptor technology.

First American Financial Corporation is an American financial services company which provides title insurance and settlement services to the real estate and mortgage industries.

IMCR vs THFF — Head-to-Head

Bigger by revenue
IMCR
IMCR
1.5× larger
IMCR
$104.5M
$70.5M
THFF
Growing faster (revenue YoY)
IMCR
IMCR
+10.2% gap
IMCR
24.3%
14.1%
THFF
More free cash flow
THFF
THFF
$122.0M more FCF
THFF
$86.4M
$-35.5M
IMCR
Faster 2-yr revenue CAGR
IMCR
IMCR
Annualised
IMCR
21.7%
20.8%
THFF

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
IMCR
IMCR
THFF
THFF
Revenue
$104.5M
$70.5M
Net Profit
$21.5M
Gross Margin
97.4%
Operating Margin
-18.8%
37.4%
Net Margin
30.4%
Revenue YoY
24.3%
14.1%
Net Profit YoY
32.1%
EPS (diluted)
$-0.61
$1.81

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IMCR
IMCR
THFF
THFF
Q4 25
$104.5M
$70.5M
Q3 25
$103.7M
$65.8M
Q2 25
$98.0M
$63.1M
Q1 25
$93.9M
$62.5M
Q4 24
$84.1M
$61.8M
Q3 24
$80.2M
$58.4M
Q2 24
$75.4M
$49.2M
Q1 24
$70.5M
$48.4M
Net Profit
IMCR
IMCR
THFF
THFF
Q4 25
$21.5M
Q3 25
$-177.0K
$20.8M
Q2 25
$-10.3M
$18.6M
Q1 25
$5.0M
$18.4M
Q4 24
$16.2M
Q3 24
$8.7M
$8.7M
Q2 24
$-11.6M
$11.4M
Q1 24
$-24.4M
$10.9M
Gross Margin
IMCR
IMCR
THFF
THFF
Q4 25
97.4%
Q3 25
99.5%
Q2 25
98.9%
Q1 25
99.1%
Q4 24
99.6%
Q3 24
99.4%
Q2 24
97.7%
Q1 24
99.7%
Operating Margin
IMCR
IMCR
THFF
THFF
Q4 25
-18.8%
37.4%
Q3 25
-6.9%
39.2%
Q2 25
-15.2%
36.2%
Q1 25
-3.9%
38.1%
Q4 24
-23.1%
32.4%
Q3 24
-10.6%
17.9%
Q2 24
-21.2%
27.6%
Q1 24
-37.6%
27.2%
Net Margin
IMCR
IMCR
THFF
THFF
Q4 25
30.4%
Q3 25
-0.2%
31.6%
Q2 25
-10.5%
29.5%
Q1 25
5.4%
29.5%
Q4 24
26.3%
Q3 24
10.9%
15.0%
Q2 24
-15.4%
23.1%
Q1 24
-34.7%
22.6%
EPS (diluted)
IMCR
IMCR
THFF
THFF
Q4 25
$-0.61
$1.81
Q3 25
$0.00
$1.75
Q2 25
$-0.20
$1.57
Q1 25
$0.10
$1.55
Q4 24
$-0.47
$1.37
Q3 24
$0.17
$0.74
Q2 24
$-0.23
$0.96
Q1 24
$-0.49
$0.93

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IMCR
IMCR
THFF
THFF
Cash + ST InvestmentsLiquidity on hand
$864.2M
Total DebtLower is stronger
$188.2M
Stockholders' EquityBook value
$381.0M
$650.9M
Total Assets
$1.1B
$5.8B
Debt / EquityLower = less leverage
0.29×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IMCR
IMCR
THFF
THFF
Q4 25
$864.2M
Q3 25
$892.4M
Q2 25
$882.8M
Q1 25
$837.0M
Q4 24
$820.4M
Q3 24
$901.3M
Q2 24
$859.6M
Q1 24
$832.8M
Total Debt
IMCR
IMCR
THFF
THFF
Q4 25
$188.2M
Q3 25
$170.5M
Q2 25
$122.7M
Q1 25
$124.9M
Q4 24
$28.1M
Q3 24
$438.7M
$30.5M
Q2 24
$452.5M
$108.6M
Q1 24
$452.5M
$58.6M
Stockholders' Equity
IMCR
IMCR
THFF
THFF
Q4 25
$381.0M
$650.9M
Q3 25
$396.6M
$622.2M
Q2 25
$388.5M
$587.7M
Q1 25
$378.5M
$571.9M
Q4 24
$360.7M
$549.0M
Q3 24
$377.8M
$566.0M
Q2 24
$359.1M
$530.7M
Q1 24
$359.5M
$520.8M
Total Assets
IMCR
IMCR
THFF
THFF
Q4 25
$1.1B
$5.8B
Q3 25
$1.1B
$5.7B
Q2 25
$1.1B
$5.6B
Q1 25
$1.0B
$5.5B
Q4 24
$1.0B
$5.6B
Q3 24
$1.1B
$5.5B
Q2 24
$1.0B
$4.9B
Q1 24
$994.0M
$4.9B
Debt / Equity
IMCR
IMCR
THFF
THFF
Q4 25
0.29×
Q3 25
0.27×
Q2 25
0.21×
Q1 25
0.22×
Q4 24
0.05×
Q3 24
1.16×
0.05×
Q2 24
1.26×
0.20×
Q1 24
1.26×
0.11×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IMCR
IMCR
THFF
THFF
Operating Cash FlowLast quarter
$-32.7M
$90.4M
Free Cash FlowOCF − Capex
$-35.5M
$86.4M
FCF MarginFCF / Revenue
-34.0%
122.5%
Capex IntensityCapex / Revenue
2.8%
5.6%
Cash ConversionOCF / Net Profit
4.21×
TTM Free Cash FlowTrailing 4 quarters
$-15.1M
$144.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IMCR
IMCR
THFF
THFF
Q4 25
$-32.7M
$90.4M
Q3 25
$-4.5M
$26.9M
Q2 25
$26.0M
$12.7M
Q1 25
$435.0K
$21.1M
Q4 24
$-14.0M
$60.4M
Q3 24
$21.1M
$23.3M
Q2 24
$23.5M
$8.8M
Q1 24
$-4.6M
$12.4M
Free Cash Flow
IMCR
IMCR
THFF
THFF
Q4 25
$-35.5M
$86.4M
Q3 25
$-5.2M
$25.8M
Q2 25
$25.6M
$11.6M
Q1 25
$137.0K
$20.5M
Q4 24
$-17.5M
$54.3M
Q3 24
$20.3M
$19.5M
Q2 24
$23.1M
$8.4M
Q1 24
$-5.0M
$11.5M
FCF Margin
IMCR
IMCR
THFF
THFF
Q4 25
-34.0%
122.5%
Q3 25
-5.0%
39.2%
Q2 25
26.1%
18.4%
Q1 25
0.1%
32.8%
Q4 24
-20.9%
87.8%
Q3 24
25.3%
33.5%
Q2 24
30.7%
17.2%
Q1 24
-7.1%
23.7%
Capex Intensity
IMCR
IMCR
THFF
THFF
Q4 25
2.8%
5.6%
Q3 25
0.7%
1.7%
Q2 25
0.4%
1.8%
Q1 25
0.3%
0.9%
Q4 24
4.3%
9.9%
Q3 24
1.0%
6.5%
Q2 24
0.4%
0.7%
Q1 24
0.6%
2.0%
Cash Conversion
IMCR
IMCR
THFF
THFF
Q4 25
4.21×
Q3 25
1.29×
Q2 25
0.68×
Q1 25
0.09×
1.14×
Q4 24
3.72×
Q3 24
2.42×
2.67×
Q2 24
0.77×
Q1 24
1.14×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons